• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

振荡呼气正压与用力呼气技术对哮喘或慢性阻塞性肺疾病患者痰液细胞计数及诱导痰量的影响

Influence of oscillating positive expiratory pressure and the forced expiratory technique on sputum cell counts and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease.

作者信息

Morsch Ana Lúcia Bernardo de Carvalho, Amorim Maria Marta, Barbieri Andréa, Santoro Llka Lopes, Fernandes Ana Luisa Godoy

机构信息

Universidade Regional Integrada, Erechim, RS, Brasil.

出版信息

J Bras Pneumol. 2008 Dec;34(12):1026-32. doi: 10.1590/s1806-37132008001200007.

DOI:10.1590/s1806-37132008001200007
PMID:19180337
Abstract

OBJECTIVE

To evaluate whether respiratory therapy techniques influence the number of cells within and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD).

METHODS

Randomized clinical trial, in which patients with asthma or COPD under intervention (n = 16 and 10, respectively) were compared with control groups (n = 16 and 10). Patients in the asthma/intervention (A/I) and COPD/intervention (C/I) groups were submitted to oscillating positive expiratory pressure maneuvers for 5 min, followed by 10 forced expiratory technique sequences. These patients were also submitted to an induced sputum protocol with inhaled hypertonic saline (3%, 4% or 5%; A/I group) or inhaled isotonic saline (C/I group). The asthma/control (A/C) and COPD/control (C/C) groups were submitted only to the standard induced sputum protocol.

RESULTS

The final mean weight of the sputum samples was significantly greater in the A/I group than in the A/C group (2,767.25 +/- 998.08 mg vs. 1,689.17 +/- 1,189.96 mg; p = 0.03). The mean/median total cell counts (x10(6)/mL) were higher in the A/I and C/I groups than in the A/C and C/C groups (4.06/0.95 and 0.63/0.39, p = 0.05, vs. 5.08/1.77 and 0.64/0.40, p = 0.02). There were no statistically significant differences among the groups in terms of cell viability.

CONCLUSIONS

The use of respiratory therapy techniques can increase sputum sample weight in asthma patients, as well as increasing total cell counts in patients with asthma or COPD.

摘要

目的

评估呼吸治疗技术是否会影响哮喘或慢性阻塞性肺疾病(COPD)患者痰液中的细胞数量和诱导痰量。

方法

随机临床试验,将接受干预的哮喘或COPD患者(分别为n = 16和10)与对照组(n = 16和10)进行比较。哮喘/干预(A/I)组和COPD/干预(C/I)组的患者接受5分钟的振荡呼气末正压操作,随后进行10次用力呼气技术序列。这些患者还接受了吸入高渗盐水(3%、4%或5%;A/I组)或吸入等渗盐水(C/I组)的诱导痰方案。哮喘/对照组(A/C)和COPD/对照组(C/C)仅接受标准诱导痰方案。

结果

A/I组痰液样本的最终平均重量显著高于A/C组(2,767.25 +/- 998.08毫克对1,689.17 +/- 1,189.96毫克;p = 0.03)。A/I组和C/I组的平均/中位数总细胞计数(x10(6)/毫升)高于A/C组和C/C组(4.06/0.95和0.63/0.39,p = 0.05,对5.08/1.77和0.64/0.40,p = 0.02)。各组之间在细胞活力方面无统计学显著差异。

结论

呼吸治疗技术的使用可增加哮喘患者的痰液样本重量,以及增加哮喘或COPD患者的总细胞计数。

相似文献

1
Influence of oscillating positive expiratory pressure and the forced expiratory technique on sputum cell counts and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease.振荡呼气正压与用力呼气技术对哮喘或慢性阻塞性肺疾病患者痰液细胞计数及诱导痰量的影响
J Bras Pneumol. 2008 Dec;34(12):1026-32. doi: 10.1590/s1806-37132008001200007.
2
Airway inflammation and cellular stress in noneosinophilic atopic asthma.非嗜酸性粒细胞性特应性哮喘中的气道炎症与细胞应激
Chest. 2006 May;129(5):1194-202. doi: 10.1378/chest.129.5.1194.
3
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease.健康受试者、哮喘患者和慢性阻塞性肺疾病患者在痰液诱导15分钟期间痰液成分的变化。
Respir Med. 2007 Jul;101(7):1543-8. doi: 10.1016/j.rmed.2006.12.009. Epub 2007 Jan 26.
4
Positive expiratory pressure via mask does not improve ventilation inhomogeneity more than huffing and coughing in individuals with stable chronic obstructive pulmonary disease and chronic sputum expectoration.经面罩给予正压呼气对稳定期慢性阻塞性肺疾病且持续有痰的患者来说,改善通气不均的效果并不优于哈气和咳嗽。
Respiration. 2014;87(1):38-44. doi: 10.1159/000348546. Epub 2013 Jun 8.
5
Use of induced sputum cell counts to investigate airway inflammation in asthma.利用诱导痰细胞计数研究哮喘患者的气道炎症。
Thorax. 1992 Jan;47(1):25-9. doi: 10.1136/thx.47.1.25.
6
Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.不同疾病严重程度的哮喘-慢性阻塞性肺疾病重叠综合征患者呼出气一氧化氮分数水平与吸入性糖皮质激素疗效的关系
J Korean Med Sci. 2017 Mar;32(3):439-447. doi: 10.3346/jkms.2017.32.3.439.
7
Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.痰液分类细胞计数在检测慢性支气管哮喘或慢性阻塞性肺疾病患者气道炎症中的作用。
Thorax. 1996 Oct;51(10):1000-4. doi: 10.1136/thx.51.10.1000.
8
Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma.慢性阻塞性肺疾病患者与哮喘患者的痰中3型五聚体蛋白水平存在差异。
Ann Allergy Asthma Immunol. 2015 Dec;115(6):485-9. doi: 10.1016/j.anai.2015.10.003. Epub 2015 Oct 24.
9
Effect of inhaled steroids on increased collagen synthesis in asthma.
Respiration. 2007;74(2):154-8. doi: 10.1159/000091390. Epub 2006 Feb 6.
10
Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).新型磷酸二酯酶-4抑制剂BAY 19-8004对哮喘和慢性阻塞性肺疾病(COPD)肺功能及气道炎症的疗效
Pulm Pharmacol Ther. 2003;16(6):341-7. doi: 10.1016/S1094-5539(03)00090-7.

引用本文的文献

1
Randomized trial of physiotherapy and hypertonic saline techniques for sputum induction in asthmatic children and adolescents.随机对照试验:物理疗法和高渗盐水技术在诱导哮喘儿童和青少年排痰中的应用
Clinics (Sao Paulo). 2020 Jan 24;75:e1512. doi: 10.6061/clinics/2020/e1512. eCollection 2020.
2
Airway clearance techniques for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的气道廓清技术
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD008328. doi: 10.1002/14651858.CD008328.pub2.